Psychiatry & Neurology Doctors in Abingdon, VA Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Shaena Blevins, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 312, Abingdon, VA 24211 Phone: 276-258-3733

Marivi A Niebauer, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 312, Abingdon, VA 24211 Phone: 276-258-3733    Fax: 276-258-3734

Dr. Keith Anthony White, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 300 Valley St Ne, Abingdon, VA 24210 Phone: 276-206-8197

Dr. Emily Simoson Shields, M.D. Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 16000 Johnston Memorial Dr, Suite 312, Abingdon, VA 24211 Phone: 276-258-3733    Fax: 276-258-3734

Vanessa A Camperlengo, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 610 Campus Dr, Abingdon, VA 24210 Phone: 276-525-1587    Fax: 276-525-1609

Dr. Monika Elizabeth Pelly, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 468 E Main St, Ste 300a, Abingdon, VA 24210 Phone: 276-608-4388

Dr. Shaji Justus Puthuvel, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 610 Campus Dr, Suite 110, Abingdon, VA 24210 Phone: 276-525-1442

News Archive

Public distrust in government-led initiatives could hinder efforts to stop Zika, other infectious diseases

Nearly half of New Hampshire residents surveyed believe scientists adjust their findings to get the answers they want, and these people are significantly less likely to trust the Centers for Disease Control (CDC) as a source of information on the Zika virus, according to new research released by the Carsey School of Public Policy at the University of New Hampshire.

Arrays of nanoscale sensors detect flaws in drugs and help improve production

​MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs - especially those based on antibodies - more safely and efficiently.

DNDi receives 2013 BBVA Foundation Frontiers of Knowledge and Culture Award

Today in Madrid, Spain, the Drugs for Neglected Diseases initiative (DNDi) received the BBVA Foundation 'Frontiers of Knowledge and Culture Award for Development Cooperation'. This EUR 400,000 award will be presented at a ceremony in Madrid, Spain, in June of this year.

Safeguard Scientifics sells additional 2.4 million shares of its position in Clarient

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it has sold an additional 2.4 million shares of its position in Clarient, Inc. (Nasdaq: CLRT) through a Clarient shelf registration on Form S-3 that was declared effective by the Securities and Exchange Commission on August 20, 2009.

Read more Medical News

› Verified 1 days ago